vincristine as a multi-agent chemotherapy regimen in gestational trophoblastic neoplasia

Overview of attention for article published in Frontiers in oncology, October 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 3 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 20,900 followers.

RT @FrontOncology: New research: The efficacy and safety of 5-fluorouracil/cisplatin/vincristine as a multi-agent chemotherapy regimen in g…

01 Nov 2023

Reply Repost Favourite

RT @FrontOncology: New research: The efficacy and safety of 5-fluorouracil/cisplatin/vincristine as a multi-agent chemotherapy regimen in g…

01 Nov 2023

Reply Repost Favourite

RT @FrontOncology: New research: The efficacy and safety of 5-fluorouracil/cisplatin/vincristine as a multi-agent chemotherapy regimen in g…

01 Nov 2023

Reply Repost Favourite

New research: The efficacy and safety of 5-fluorouracil/cisplatin/vincristine as a multi-agent chemotherapy regimen in gestational trophoblastic neoplasia: Objective To determine the efficacy and safety of the 5-fluorouracil (5-FU), cisplatin,… https://t.

01 Nov 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.